J Clin Oncol
Sibylle Loibl, MD, PhD, German Breast Group c/o GBG Forschungs GmbH, Neu-Isenburg, Germany, Center for Hematology and Oncology Bethanien, Frankfurt, Germany; Valentina Nekljudova, PhD, German Breast Group c/o GBG Forschungs GmbH, Neu-Isenburg, Germany; and Carsten Denkert, MD, PhD, Institute of Pathology, University Hospital Marburg and Philipps-University Marburg, Marburg, Germany.
Published: September 2021